Princeton Global Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Princeton Global Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-330	Closed	-$15K	–	393
2019 Q2	$15K	Buy	+330	New	+$9.27K	0.01%	307

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Princeton Global Asset Management's ARRY Position: Q3 2019 in Review

Princeton Global Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 330 shares — an estimated $15K sold.

Princeton Global Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $15K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Princeton Global Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Princeton Global Asset Management sold 330 Array Biopharma Inc shares in Q3 2019, an estimated $15K.
Princeton Global Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Princeton Global Asset Management's Array Biopharma Inc position peaked at $15K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Princeton Global Asset Management's 13F filing for Q3 2019, filed 3 Dec 2019.